Stocklytics Platform
Asset logo for symbol PROK
ProKidney
PROK39
$2.00arrow_drop_up8.64%$0.15
Penny Stock
Asset logo for symbol PROK
PROK39

$2.00

arrow_drop_up8.64%

Performance History

Chart placeholder
Key Stats
Open$1.89
Prev. Close$1.85
EPS-0.54
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$255.93M
PE Ratio-
LOWHIGH
Day Range1.86
2.20
52 Week Range1.12
4.63
Ratios
Revenue-
EBITDA Margin %-
EPS-0.54

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About ProKidney (PROK)

ProKidney Corp. (PROK) is a leading healthcare company specializing in kidney-related products and services. With a rich history and a strong presence in the market, PROK has established itself as a trusted name in the industry. The company's stock price has shown consistent growth over the years, reflecting the investor confidence in its performance. PROK stock has witnessed significant appreciation, making it an attractive choice for investors looking for long-term returns.
PROK stock has seen a positive trend in recent years, with its value showing an upward trajectory. The company's commitment to innovation and delivering high-quality healthcare solutions has played a crucial role in driving this growth. Its extensive range of kidney-related products and services has helped it establish a strong foothold in the industry. PROK's stock price history demonstrates its ability to generate value for shareholders, making it a compelling investment option.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Timothy A. Bertram D.V.M., Ph.D.
Headquarters
Winston-Salem
Employees
87
Exchange
NASDAQ
add ProKidney to watchlist

Keep an eye on ProKidney

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the market capitalization of ProKidney (PROK)?

ProKidney (PROK) has a market capitalization of $255.94M. The average daily trading volume is 2.07, indicating the stock's liquidity and investor engagement.
help

What is ProKidney's (PROK) price per share?

The current price per share for ProKidney (PROK) is $2. The stock has seen a price change of $0.16 recently, indicating a 8.65% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for ProKidney (PROK)?

For ProKidney (PROK), the 52-week high is $4.63, which is 131.5% from the current price. The 52-week low is $1.12, the current price is 78.57% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is ProKidney (PROK) a growth stock?

ProKidney (PROK) has shown an average price growth of -2.94% over the past three years. It has received a score of 14 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ProKidney as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is ProKidney (PROK) stock price performance year to date (YTD)?

As of the latest data, ProKidney (PROK) has a year-to-date price change of 16.96%. Over the past month, the stock has experienced a price change of 11.73%. Over the last three months, the change has been -9.5%. Over the past six months, the figure is -46.09%.
help

Is ProKidney (PROK) a profitable company?

ProKidney (PROK) has a net income of -$135.45M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$151.52M. Furthermore, the EBITDA is -$145.99M.

Take Your Investments to a Whole New Level